Patrick Dallemagne

Synthesis, Antimalarial Activity, and Molecular Modeling of New Pyrrolo[1,2-<i>a</i>]quinoxalines, Bispyrrolo[1,2-<i>a</i>]quinoxalines, Bispyrido[3,2-<i>e</i>]pyrrolo[1,2-<i>a</i>]pyrazines, and Bispyrrolo[1,2-<i>a</i>]thieno[3,2-<i>e</i>]pyrazines

Jean Guillon, Philippe Grellier, Mehdi Labaïed et al. · Journal of Medicinal Chemistry · 2004 · 169 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives

Pascal Sonnet, Patrick Dallemagne, Jean Guillon et al. · Bioorganic & Medicinal Chemistry · 2000 · 124 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

Cédric Lecoutey, Damien Hédou, Thomas Fréret et al. · Proceedings of the National Academy of Sciences · 2014 · 119 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT₄R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride

Christophe Rochais, Cédric Lecoutey, Florence Gaven et al. · Journal of Medicinal Chemistry · 2015 · 117 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis of new pyrrolo[1,2-a]quinoxalines: potential non-peptide glucagon receptor antagonists

Jean Guillon, Patrick Dallemagne, Bruno Pfeiffer et al. · European Journal of Medicinal Chemistry · 1998 · 86 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11